Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat + Luspatercept vs Luspatercept in Refractory MDS-RS
NCT06006949Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roxadustat in myelodysplastic syndrome (MDS), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
roxadustat
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT06006949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06006949.